News
Stay updated with the latest innovations and news from Quantoom Biosciences!
Medellín, Colombia and Nivelles, Belgium – June 23, 2025 VaxThera, a biotechnology company that produce vaccines and biologics, and Quantoom…
Quantoom’s customers can now access TriLink’s CleanCap mRNA capping technology; Agreement supports future expansion of essential therapeutics & vaccines in…
REDMOND, Wash., & NIVELLES, Belgium – May 15, 2025 Inventprise Inc., a clinical-stage vaccine invention company, announced today its selection…
NIVELLES, Belgium – April 14, 2025 Quantoom Biosciences, a full-stack RNA partner for mRNA- and saRNA-based vaccines and therapeutics, is…
Manchester, CT, USA & NIVELLES, Belgium – March 31, 2025 Quantoom Biosciences and DIANT Pharma Inc. are proud to announce…
March 2025 At the end of February, CAPTIVATE-EU held its annual meeting in Barcelona! Scientists Youlia Serikova and Erica Pasini…
Pirbright, UK & Nivelles, Belgium – Thursday, March 13, 2025 The Centre for Veterinary Vaccine Innovation and Manufacturing (CVIM), part…
Wednesday, March 5, 2025 TechInvention Lifecare Pvt. Ltd. (TechInvention) is proud to announce a strategic collaboration with Belgium-based Quantoom Biosciences…
Cairo, Egypt – February 5, 2025 – Africa’s EVA Pharma, France’s DNA Script, and Belgium’s Quantoom Biosciences have signed a…
Rio de Janeiro, Brazil – November 29, 2024 – During the Belgian Economic Mission to Brazil, a historic Memorandum of…
ST Pharm, a leading technology-driven RNA CDMO, and Quantoom Biosciences (also referred as “Quantoom”), a specialized RNA technology platform developer,…
DURHAM, North Carolina – Quantoom Biosciences S.A. (“Quantoom”), part of Univercells S.A., focused on mRNA production technologies for vaccines and…
Nivelles, Belgium – Quantoom Biosciences S.A. (“Quantoom”), a subsidiary of Univercells S.A., proudly announces the extension of the Ntensify™ product…
Quantoom Biosciences S.A. (“Quantoom”), part of Univercells S.A. is proud to announce its significant collaboration with the Institute of Technology…
The Ntensify™ Midi System Sets the Stage for Equitable Vaccine Access Quantoom Biosciences S.A. (“Quantoom”), a Univercells company, proudly announces…
Quantoom Biosciences (‘Quantoom’) is thrilled to announce a new collaboration with Stevanato Group, a leading global provider of drug containment and…
Quantoom Biosciences S.A. (“Quantoom”), a Univercells company, is proud to unveil the latest addition to its offering: a service for…
Univercells S.A. (Univercells) today announced its acquisition of SynHelix, a biotechnology company that aims to debottleneck biotherapeutics development through an unprecedented…
